Company / EPS (Diluted)
PAVmed Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$14.90
FY2025
5-year range
-$15.03 / $14.90
FY2021-FY2025
Trend
+262.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed +263% YoY in FY2025, a notable deviation from the 3-year average annual change of -562%.
Based on SEC 10-K filings.
14.90 in FY2025.
Improved from $-15.03 to $14.90 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 262.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.90 | +262.7% |
| FY2024 | -$9.16 | +39.1% |
| FY2023 | -$15.03 | - |
| FY2022 | - | - |
| FY2021 | -$0.72 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026